Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 193

1.

The Development of the Pediatric Migraine Action Plan (PedMAP).

Turner SB, Rende EK, Szperka CL, Hershey AD, Gelfand AA.

Headache. 2019 Nov;59(10):1671-1672. doi: 10.1111/head.13666. No abstract available.

PMID:
31710107
2.

Pediatric Migraine Action Plan (PedMAP).

Turner SB, Rende EK, Pezzuto T, Weaver S, Henderlong-Kropp A, Greene KA, Bicknese AR, Dilts JJ, Gautreaux J, Victorio MCC, Strauss LD, Lagman-Bartolome AM, Szperka CL, Yonker M, Hershey AD, Gelfand AA.

Headache. 2019 Nov;59(10):1871-1873. doi: 10.1111/head.13681. No abstract available.

PMID:
31710105
3.

Clinical presentation, diagnosis and polysomnographic findings in children with migraine referred to sleep clinics.

Armoni Domany K, Nahman-Averbuch H, King CD, Dye T, Xu Y, Hossain M, Hershey AD, Simakajornboon N.

Sleep Med. 2019 Jun 8;63:57-63. doi: 10.1016/j.sleep.2019.04.023. [Epub ahead of print]

PMID:
31606650
4.

Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.

Oskoui M, Pringsheim T, Holler-Managan Y, Potrebic S, Billinghurst L, Gloss D, Hershey AD, Licking N, Sowell M, Victorio MC, Gersz EM, Leininger E, Zanitsch H, Yonker M, Mack K.

Headache. 2019 Sep;59(8):1158-1173. doi: 10.1111/head.13628.

PMID:
31529481
5.

New Guidelines: Interpretation, Application and the Future.

Hershey AD, Oskoui M, Pringsheim T, Holler-Managan Y, Potrebic S, Billinghurst L, Gloss D, Licking N, Sowell M, Victorio MC, Gersz E, Vrijsen E, Zanitsch H, Yonker M, Mack K, Gelfand AA, Szperka CL, Powers SW.

Headache. 2019 Sep;59(8):1133-1143. doi: 10.1111/head.13629. No abstract available.

PMID:
31529478
6.

Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.

Oskoui M, Pringsheim T, Billinghurst L, Potrebic S, Gersz EM, Gloss D, Holler-Managan Y, Leininger E, Licking N, Mack K, Powers SW, Sowell M, Cristina Victorio M, Yonker M, Zanitsch H, Hershey AD.

Headache. 2019 Sep;59(8):1144-1157. doi: 10.1111/head.13625.

PMID:
31529477
7.

Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.

Oskoui M, Pringsheim T, Holler-Managan Y, Potrebic S, Billinghurst L, Gloss D, Hershey AD, Licking N, Sowell M, Victorio MC, Gersz EM, Leininger E, Zanitsch H, Yonker M, Mack K.

Neurology. 2019 Sep 10;93(11):487-499. doi: 10.1212/WNL.0000000000008095. Epub 2019 Aug 14.

PMID:
31413171
8.

Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.

Oskoui M, Pringsheim T, Billinghurst L, Potrebic S, Gersz EM, Gloss D, Holler-Managan Y, Leininger E, Licking N, Mack K, Powers SW, Sowell M, Victorio MC, Yonker M, Zanitsch H, Hershey AD.

Neurology. 2019 Sep 10;93(11):500-509. doi: 10.1212/WNL.0000000000008105. Epub 2019 Aug 14.

PMID:
31413170
9.

Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition.

Abu-Arafeh I, Hershey AD, Diener HC, Tassorelli C; Clinical Trials Standing Committee and the Child and Adolescent Standing Committee of the International Headache Society.

Cephalalgia. 2019 Jun;39(7):803-816. doi: 10.1177/0333102419842188. Epub 2019 Apr 4.

PMID:
30947525
10.

Predictors of Short-Term Prognosis While in Pediatric Headache Care: An Observational Study.

Orr SL, Turner A, Kabbouche MA, Horn PS, O'Brien HL, Kacperski J, LeCates S, White S, Weberding J, Miller MN, Powers SW, Hershey AD.

Headache. 2019 Apr;59(4):543-555. doi: 10.1111/head.13477. Epub 2019 Jan 23.

PMID:
30671933
11.

Increased pain sensitivity but normal pain modulation in adolescents with migraine.

Nahman-Averbuch H, Leon E, Hunter BM, Ding L, Hershey AD, Powers SW, King CD, Coghill RC.

Pain. 2019 May;160(5):1019-1028. doi: 10.1097/j.pain.0000000000001477.

PMID:
30624343
12.

Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents.

Szperka CL, VanderPluym J, Orr SL, Oakley CB, Qubty W, Patniyot I, Lagman-Bartolome AM, Morris C, Gautreaux J, Victorio MC, Hagler S, Narula S, Candee MS, Cleves-Bayon C, Rao R, Fryer RH, Bicknese AR, Yonker M, Hershey AD, Powers SW, Goadsby PJ, Gelfand AA.

Headache. 2018 Nov;58(10):1658-1669. doi: 10.1111/head.13414. Epub 2018 Oct 15. No abstract available.

13.

Have You Got the Power? Why Statistical Power Calculations Are Critical to Research Design.

Orr SL, Hershey AD.

Headache. 2018 Sep;58(8):1192-1193. doi: 10.1111/head.13392. Epub 2018 Aug 20. No abstract available.

PMID:
30125351
14.

Paediatric migraine: evidence-based management and future directions.

Orr SL, Kabbouche MA, O'Brien HL, Kacperski J, Powers SW, Hershey AD.

Nat Rev Neurol. 2018 Sep;14(9):515-527. doi: 10.1038/s41582-018-0042-7. Review.

PMID:
30038237
15.

Predictors of First-Line Treatment Success in Children and Adolescents Visiting an Infusion Center for Acute Migraine.

Orr SL, Kabbouche MA, Horn PS, O'Brien HL, Kacperski J, LeCates S, White S, Weberding J, Miller MN, Powers SW, Hershey AD.

Headache. 2018 Sep;58(8):1194-1202. doi: 10.1111/head.13340. Epub 2018 Jun 21.

PMID:
29926909
16.

A pilot investigation of a mobile phone application and progressive reminder system to improve adherence to daily prevention treatment in adolescents and young adults with migraine.

Ramsey RR, Holbein CE, Powers SW, Hershey AD, Kabbouche MA, O'Brien HL, Kacperski J, Shepard J, Hommel KA.

Cephalalgia. 2018 Dec;38(14):2035-2044. doi: 10.1177/0333102418756864. Epub 2018 Apr 10.

PMID:
29635937
17.

Research Agenda for the Prevention of Pain and Its Impact: Report of the Work Group on the Prevention of Acute and Chronic Pain of the Federal Pain Research Strategy.

Gatchel RJ, Reuben DB, Dagenais S, Turk DC, Chou R, Hershey AD, Hicks GE, Licciardone JC, Horn SD.

J Pain. 2018 Aug;19(8):837-851. doi: 10.1016/j.jpain.2018.02.015. Epub 2018 Mar 22.

PMID:
29578089
18.

CGRP - The Next Frontier for Migraine.

Hershey AD.

N Engl J Med. 2017 Nov 30;377(22):2190-2191. doi: 10.1056/NEJMe1712559. No abstract available.

PMID:
29171812
19.

Pediatric Migraine Disability Assessment (PedMIDAS): Translation Into Brazilian Portuguese and Cross-Cultural Adaptation.

Sampaio Rocha-Filho PA, Hershey AD.

Headache. 2017 Oct;57(9):1409-1415. doi: 10.1111/head.13159. Epub 2017 Jul 28.

PMID:
28752917
20.

Ovarian hormones, age and pubertal development and their association with days of headache onset in girls with migraine: An observational cohort study.

Martin VT, Allen JR, Houle TT, Powers SW, Kabbouche MA, O'Brien HL, Kacperski J, LeCates SL, White S, Vaughan P, Mandell K, Hershey AD.

Cephalalgia. 2018 Apr;38(4):707-717. doi: 10.1177/0333102417706980. Epub 2017 May 5.

PMID:
28474986
21.

Treatment of Pediatric Migraine.

Powers SW, Coffey CS, Hershey AD.

N Engl J Med. 2017 Apr 6;376(14):1388-9. doi: 10.1056/NEJMc1701674. No abstract available.

PMID:
28379804
22.

The Childhood and Adolescent Migraine Prevention (CHAMP) Study: "What Do We Do Now?"

Powers SW, Hershey AD, Coffey CS; CHAMP Study Group.

Headache. 2017 Feb;57(2):180-183. doi: 10.1111/head.13025. No abstract available.

PMID:
28128463
23.

Treatment Adherence in Child and Adolescent Chronic Migraine Patients: Results From the Cognitive-Behavioral Therapy and Amitriptyline Trial.

Kroon Van Diest AM, Ramsey RR, Kashikar-Zuck S, Slater S, Hommel K, Kroner JW, LeCates S, Kabbouche MA, O'Brien HL, Kacperski J, Allen JR, Peugh J, Hershey AD, Powers SW.

Clin J Pain. 2017 Oct;33(10):892-898. doi: 10.1097/AJP.0000000000000481.

24.

Trajectory of Improvement in Children and Adolescents With Chronic Migraine: Results From the Cognitive-Behavioral Therapy and Amitriptyline Trial.

Kroner JW, Peugh J, Kashikar-Zuck SM, LeCates SL, Allen JR, Slater SK, Zafar M, Kabbouche MA, O'Brien HL, Shenk CE, Kroon Van Diest AM, Hershey AD, Powers SW.

J Pain. 2017 Jun;18(6):637-644. doi: 10.1016/j.jpain.2017.01.002. Epub 2017 Jan 18.

25.

Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine.

Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, Korbee LL, Porter LL, Hershey AD; CHAMP Investigators.

N Engl J Med. 2017 Jan 12;376(2):115-124. doi: 10.1056/NEJMoa1610384. Epub 2016 Oct 27.

26.
27.

Newly Approved Agents for the Treatment and Prevention of Pediatric Migraine.

Kacperski J, Hershey AD.

CNS Drugs. 2016 Sep;30(9):837-44. doi: 10.1007/s40263-016-0375-y. Review.

PMID:
27503180
28.

In Memoriam:DonaldW.Lewis,MD(1951–2012).

Hershey AD, Gladstein J, Mack KJ.

Semin Pediatr Neurol. 2016 Feb;23(1):2-3. No abstract available.

PMID:
27464366
29.

Adherence to Biobehavioral Recommendations in Pediatric Migraine as Measured by Electronic Monitoring: The Adherence in Migraine (AIM) Study.

Kroon Van Diest AM, Ramsey R, Aylward B, Kroner JW, Sullivan SM, Nause K, Allen JR, Chamberlin LA, Slater S, Hommel K, LeCates SL, Kabbouche MA, O'Brien HL, Kacperski J, Hershey AD, Powers SW.

Headache. 2016 Jul;56(7):1137-46. doi: 10.1111/head.12836. Epub 2016 May 11.

30.

Quantitative neuromagnetic signatures of aberrant cortical excitability in pediatric chronic migraine.

Leiken KA, Xiang J, Curry E, Fujiwara H, Rose DF, Allen JR, Kacperski JE, O'Brien HL, Kabbouche MA, Powers SW, Hershey AD.

J Headache Pain. 2016;17:46. doi: 10.1186/s10194-016-0641-x. Epub 2016 Apr 26.

31.

The Childhood and Adolescent Migraine Prevention (CHAMP) Study: A Report on Baseline Characteristics of Participants.

Powers SW, Hershey AD, Coffey CS, Chamberlin LA, Ecklund DJD, Sullivan SM, Klingner EA, Yankey JW, Kashikar-Zuck S, Korbee LL, Costigan ML, Riss HH, Porter LL.

Headache. 2016 May;56(5):859-870. doi: 10.1111/head.12810. Epub 2016 Apr 4.

32.

Cognitive Behavioral Therapy plus Amitriptyline for Children and Adolescents with Chronic Migraine Reduces Headache Days to ≤4 Per Month.

Kroner JW, Hershey AD, Kashikar-Zuck SM, LeCates SL, Allen JR, Slater SK, Zafar M, Kabbouche MA, O'Brien HL, Shenk CE, Rausch JR, Kroon Van Diest AM, Powers SW.

Headache. 2016 Apr;56(4):711-6. doi: 10.1111/head.12795. Epub 2016 Mar 18.

PMID:
26992129
33.

Spatial Heterogeneity of Cortical Excitability in Migraine Revealed by Multifrequency Neuromagnetic Signals.

Xiang J, Leiken K, Degrauw X, Kay B, Fujiwara H, Rose DF, Allen JR, Kacperski JE, O'Brien HL, Kabbouche MA, Powers SW, Hershey AD.

J Pain. 2016 Jun;17(6):694-706. doi: 10.1016/j.jpain.2016.02.009. Epub 2016 Mar 10.

34.

Pediatric Headache: Where We Are and Where We Are Going.

Hershey AD.

Headache. 2015 Nov-Dec;55(10):1356-7. doi: 10.1111/head.12713. Epub 2015 Oct 16. No abstract available.

PMID:
26474312
35.

Factors Influencing Migraine Recurrence After Infusion and Inpatient Migraine Treatment in Children and Adolescents.

Cobb-Pitstick KM, Hershey AD, O'Brien HL, Kabbouche MA, LeCates S, White S, Vaughn P, Manning P, Segers A, Bush J, Horn PS, Kacperski J.

Headache. 2015 Nov-Dec;55(10):1397-403. doi: 10.1111/head.12654. Epub 2015 Sep 8.

PMID:
26345726
36.

Pediatric Headache.

Hershey AD.

Continuum (Minneap Minn). 2015 Aug;21(4 Headache):1132-45. doi: 10.1212/CON.0000000000000197. Review.

PMID:
26252596
37.
38.

Treatment of pediatric migraine.

O'Brien HL, Kabbouche MA, Kacperski J, Hershey AD.

Curr Treat Options Neurol. 2015 Jan;17(1):326. doi: 10.1007/s11940-014-0326-1.

PMID:
25617222
39.

Preventive drugs in childhood and adolescent migraine.

Kacperski J, Hershey AD.

Curr Pain Headache Rep. 2014 Jun;18(6):422. doi: 10.1007/s11916-014-0422-7. Review.

PMID:
24760491
40.

Treatment adherence in patients with headache: a systematic review.

Ramsey RR, Ryan JL, Hershey AD, Powers SW, Aylward BS, Hommel KA.

Headache. 2014 May;54(5):795-816. doi: 10.1111/head.12353. Epub 2014 Apr 17. Review.

41.

Headstrong intervention for pediatric migraine headache: a randomized clinical trial.

Rapoff MA, Connelly M, Bickel JL, Powers SW, Hershey AD, Allen JR, Karlson CW, Litzenburg CC, Belmont JM.

J Headache Pain. 2014 Feb 28;15:12. doi: 10.1186/1129-2377-15-12.

42.

Neuromagnetic abnormality of motor cortical activation and phases of headache attacks in childhood migraine.

Xiang J, Degrauw X, Korman AM, Allen JR, O'Brien HL, Kabbouche MA, Powers SW, Hershey AD.

PLoS One. 2013 Dec 27;8(12):e83669. doi: 10.1371/journal.pone.0083669. eCollection 2013.

43.

Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial.

Powers SW, Kashikar-Zuck SM, Allen JR, LeCates SL, Slater SK, Zafar M, Kabbouche MA, O'Brien HL, Shenk CE, Rausch JR, Hershey AD.

JAMA. 2013 Dec 25;310(24):2622-30. doi: 10.1001/jama.2013.282533.

44.

Monthly variation of United States pediatric headache emergency department visits.

Kedia S, Ginde AA, Grubenhoff JA, Kempe A, Hershey AD, Powers SW.

Cephalalgia. 2014 May;34(6):473-8. doi: 10.1177/0333102413515346. Epub 2013 Dec 11.

PMID:
24335850
45.

Standardization of pediatric headache evaluation and treatment in the emergency department.

Kabbouche M, Hershey AD.

J Pediatr. 2013 Dec;163(6):1545-6. doi: 10.1016/j.jpeds.2013.09.016. Epub 2013 Oct 13. No abstract available.

PMID:
24128649
46.

Relationship between daily mood and migraine in children.

Karlson CW, Litzenburg CC, Sampilo ML, Rapoff MA, Connelly M, Bickel JL, Hershey AD, Powers SW.

Headache. 2013 Nov-Dec;53(10):1624-34. doi: 10.1111/head.12215. Epub 2013 Sep 19.

47.

Altered cortical activation in adolescents with acute migraine: a magnetoencephalography study.

Xiang J, deGrauw X, Korostenskaja M, Korman AM, O'Brien HL, Kabbouche MA, Powers SW, Hershey AD.

J Pain. 2013 Dec;14(12):1553-63. doi: 10.1016/j.jpain.2013.04.009. Epub 2013 Jun 21.

48.

Childhood and Adolescent Migraine Prevention (CHAMP) study: a double-blinded, placebo-controlled, comparative effectiveness study of amitriptyline, topiramate, and placebo in the prevention of childhood and adolescent migraine.

Hershey AD, Powers SW, Coffey CS, Eklund DD, Chamberlin LA, Korbee LL; CHAMP Study Group.

Headache. 2013 May;53(5):799-816. doi: 10.1111/head.12105. Epub 2013 Apr 17.

49.

Quality of life and emotional functioning in youth with chronic migraine and juvenile fibromyalgia.

Kashikar-Zuck S, Zafar M, Barnett KA, Aylward BS, Strotman D, Slater SK, Allen JR, Lecates SL, Kabbouche MA, Ting TV, Hershey AD, Powers SW.

Clin J Pain. 2013 Dec;29(12):1066-72. doi: 10.1097/AJP.0b013e3182850544.

50.

Aberrant neuromagnetic activation in the motor cortex in children with acute migraine: a magnetoencephalography study.

Guo X, Xiang J, Wang Y, O'Brien H, Kabbouche M, Horn P, Powers SW, Hershey AD.

PLoS One. 2012;7(11):e50095. doi: 10.1371/journal.pone.0050095. Epub 2012 Nov 20.

Supplemental Content

Loading ...
Support Center